Quality Risk Management during Implementation of Phase Ⅱa Clinical Trials of Innovative Anti-tumor Drugs
ZHANG Rui, PAN Yan, WU Zhiang
Chinese Journal of Pharmacovigilance . 2020, (12): 886 -889 .  DOI: 10.19803/j.1672-8629.2020.12.08